A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or “wet” AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used with existing wet AMD treatments to save vision.
Rensselaer Polytechnic Institute’s Christopher Cioffi, Ph.D., Thomas and Constance D'Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of Ophthalmic Science at Columbia University, to develop compounds to treat dry age-related macular degeneration (AMD) and Stargardt disease — both blindness-causing diseases. The team’s work has led to the discovery of an advanced preclinical candidate. Now, Cioffi and Petrukhin have received a $6.4 million grant over five years from the National Institutes of Health’s National Eye Institute to conduct drug development work and investigational new drug (IND)-enabling toxicology studies.
Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.
Chao Zhou, a professor of biomedical engineering in the McKelvey School of Engineering at Washington University in St. Louis, has been awarded an up to $20 million contract from the Advanced Research Projects Agency for Health (ARPA-H).
Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation has named David A. Atchison, PhD, DSc, as the 2024 recipient of the Oberdorfer Award in Low Vision.
AMDF and TLI launch a campaign to raise awareness about macular degeneration with the official release of a short film featuring TLI fellow Laura Carabello.
During February’s AMD Awareness Month, the American Society of Retina Specialists (ASRS) is sharing critical knowledge on AMD to help safeguard sight.
A 2024 AMD Awareness Month Resource Page, designed for the public and journalists, offers educational content, shareable talking points, fact sheets, shareable social media graphics, videos, opportunities for action, and more.
The latest research and expertise on the flue can be found in the Influenza channel on Newswise.
The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today that Glenn Yiu, MD, PhD, has won the 2024 Carl Camras Translational Research Award.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today the 2024 recipients of the Dr. David L. Epstein Award: Yvonne Ou, MD (mentor) and Tyson Kim, MD, PhD.
Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.
Find the latest research and features on fertility in the Fertility News Source on Newswise.
With the rise in machine learning applications and artificial intelligence, it's no wonder that more and more scientists and researchers are turning to supercomputers. Supercomputers are commonly used for making predictions with advanced modeling and simulations. This can be applied to climate research, weather forecasting, genomic sequencing, space exploration, aviation engineering and more.
Below are some of the latest headlines in the Women's Health channel on Newswise.
Scientists have found a way to use nanotechnology to create a 3D ‘scaffold’ to grow cells from the retina –paving the way for potential new ways of treating a common cause of blindness.
UT Southwestern Medical Center researchers have identified a gene called Lipe that appears to be pivotal to retinal health, with mutations spurring immune activation and retinal degeneration. This is important because the retina is responsible for detecting the light that is transformed into vision. The findings, published in Communications Biology, provide clues about the mechanisms behind a variety of disorders affecting the retina, including macular degeneration and diabetic retinopathy.
The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.
New research from Boston Medical Center found a significant correlation between biomarkers in the vitreous humor of the eye and pathologically confirmed cases of Alzheimer’s disease (AD) and Chronic Traumatic Encephalopathy (CTE) in post-mortem brain and eye tissue.
Showing results
1–1 of 1
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
